Fetomaternal Medicine

FRIDAY, NOVBEMBER 11TH, 2016
HALL D
08:30-10:00 IUGR (INTRAUTERINE GROWTH RESTRICTION)
Chairpersons Michael Robson, Ireland
Dan Farine, Canada
08:30-08:50 IUGR in Twins
Isaac Blickstein, Israel
08:50-09:15 How reliable is ultrasound and doppler in prediction of extreme fetal growth retardation?
Aris Antsaklis, Greece
09:15-09:35 IUGR and fetal brain damage
Isaac Blickstein, Israel
09:35-10:00 Update on the Zika virus
Mark Yudin, Canada
10:20-11:50 PREGNANCY AFTER INFERTILITY
Capsule Pregnancy post infertility is a well-known perinatal risk beyond the multiple pregnancy issue. Can the risk be reduced?
Chairpersons Dan Farine, Canada
Felice Petraglia, Italy
10:20-10:45 Obstetric challenges of advanced maternal age and egg donation
Hanns Helmer, Austria
10:45-11:10 How to avoid multiple pregnancies; Insights from a fertility specialist
Fady I. Sharara, USA
11:10-11:30 Does the epidemic of multiple births still exist?
Isaac Blickstein, Israel
11:30-11:50 TBA
14:30-16:00 FETAL MONITORING IN THE 21ST CENTUARY
Capsule Despite the lack of real evidence to its value, continuous electronic fetal monitoring remains the mainstay in large proportion of all deliveries
Chairpersons Andrew Shennan, UK  
Gerard H.A. Visser,
The Netherlands
14:30-14:50 The FIGO CTG interpretation
Diogo Ayres de Campos, Portugal
14:50-15:15 CTG supporting mobility in labor
Jenny Smith, UK
15:15-15:35 Auscultation vs. electronic fetal monitoring
Dan Farine, Canada
15:35-16:00 Pittfalls in CTG monitoring
Gerard H.A. Visser, The Netherlands
16:30-18:00 PREVENTION OF PREECLAMPSIA
Capsule The ability to predict changes in markers, weeks before the onset of preeclampsia is the first step in offering a prevention plan. What is the medical benefit of prediction? Could close surveillance of the patient at risk prevent the pathology or save maternal and fetal life?
Chairpersons Diogo Ayres de Campos, Portugal
Aris Antsaklis, Greece
16:30-16:55 The best method to predict hypertension
Andrew Shennan, UK
16:55-17:15 The best method to prevent preeclampsia
Aris Antsaklis, Greece
17:15-17:40 Should we screen for maternal and child hypertension after birth?
Christianne De Groot, The Netherlands
17:40-18:00 Screening for Thrombophilia and heparin to prevent fetal Death: When and why?
Chiara Benedetto, Italy
SATURDAY, NOVEMBER 12, 2016
HALL D
08:30-10:00 PRETERM BIRTH
Capsule Did we make any progress in the prevention of preterm birth?
Chairpersons Michael Schumacher, France
Isaac Blickstein, Israel
08:30-08:50 The controversy goes on: Progesterone, Cerclage or Arabin Pessary? Progesterone Vs Arabin
Andrew Shennan, UK
08:50-09:15 Preterm birth: Still an enigma but progesterone can help to prevent
Jane E. Norman, UK
09:15-09:40 Treatment of (threatening) preterm birth: Insights from recent RCTs
Ben W. J. Mol, Australia
09:40-10:00 New approaches to predict the outcome of threatened or suspected preterm labor
Gian Carlo Di Renzo, Italy
10:20-11:50 NEW INSIGHTS ON PREMATURITY
Organized by the Preis School, Permanent International and European School in Perinatal, Neonatal and Reproductive Medicine, Italy
Capsule Premature labor and delivery is a major risk facing the fetus lending great impetus to research, and understanding how to do more to prevent it
Chairpersons Gian Carlo Di Renzo, Italy
Gerard H.A. Visser, The Netherlands
10:20-10:40 Introductory lecture: Preterm birth: A great obstetrical syndrome
Gian Carlo Di Renzo
, Italy
10:40-11:00 The pros and cons of Corticosteroids, Tocolysis and Magnesium Sulfate in the management of preterm delivery
Gerard H.A. Visser, The Netherlands
11:00-11:25 Basic and clinical application of progesterone in obstetrics
Paul Piette, Belgium
11:25-11:50 Progesterone and neurodevelopment
Michael Schumacher, France
12:10-13:40 INNOVATIONS – FROM NEW IDEAS TO CLINICAL TOOLS
12:10-12:25 Hystero-Salpingo Foam Sonography (HyFoSy)
A simple office based technique to check tubal patency
http://www.iq-medicalventures.com/products/ExEm-Foam-Kit/media/
Mark Hans Emanuel, The Netherlands
12:25-12:40 Pregnabit
The first comprehensive telemedical CTG solution for fetal health monitoring
http://www.pregnabit.com/en/
Magdalena Sekowska, Poland
12:40-12:55 Why you need CTG Gameplan?
CTG Gameplan is an innovative training system that will make your CTG interpretation easier, and reduce the risk of unsafe intervention
Gloria Esegbona,
12:55-13:10 Vulvovaginal atrophy: What can be achieved by laser?
Zdenko Vizintin, Slovenia
13:10-13:20 COGI24-1305: Performance verification of the Diafert® granulocyte colony-stimulating factor
Fabian Somers, USA
16:30-18:00 GESTATIONAL DIABETES
Chairpersons Chiara Benedetto, Italy
Gerard H.A. Visser
, The Netherlands
16:30-16:50 Obesity and GDM: Which is a more important risk factor for PET?
Aris Antsaklis, Greece
16:50-17:15 New treatment strategies (oral antidiabetics; continues glucose monitoring) for gestational diabetes
Arie Franx, The Netherlands
17:15-17:40 Can fetal macrosomia be predicted and prevented?
Isaac Blickstein, Israel
17:40-18:00 Macrosomia with and without diabetes: Does it make a difference?
Dan Farine, Canada
SUNDAY, NOVEMBER 13TH, 2016
HALL D
08:30-10:00 CAESEREAN SECTION
Chairpersons Dan Farine, Canada
Eva Pajkrt, The Netherlands
08:30-09:00 Debate: VBAC is risky for the woman, child and physician
True: Eva Pajkrt, The Netherlands
Not True: Michael Robson, Ireland
Discussion
09:00-09:30 Why do niches develop in caesarean uterine scars and are they a problem
Judith A.F. Hurine, The Netherlands
09:30-10:00 Oxytocin to accelerate or induce labour: Time for reflection and standardisation
Michael Robson, Ireland
10:20-11:50 SCREENING TO ALL BY EVERY TOOL?
RTD with the panelists and audience
Moderators Michael Robson, Ireland
Dan Farine, Canada
Discussants Chiara Benedetto, Italy
Arie Franx, Netherlands
Gerard H.A. Visser, Netherlands
Diogo Ayres de Campos, Portugal
Questions to the panel:
  1. Screening for thyroid dysfunction
  2. Screening for GBS, CMV, Bacterial vaginosis
  3. Cervical length for all?
  4. How many scans for anomalies are needed?
  5. Screening for aneuploidy to all?
  6. Should we screen for GDM before 24 weeks?
  7. How to define well glycemic control?
  8. Vitamins, Omega 3 during pregnancy: Worth taking?
  9. What is the optimal weight gain? Maternal risks
  10. Exercise – What is OK and what is not
  11. Immunizations in pregnancy: which? when?